<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">POLYTHIAZIDE</span><br/>(pol-i-thye'a-zide)<br/><span class="topboxtradename">Renese<br/></span><b>Classifications:</b> <span class="classification">electrolytic and water balance agent</span>; <span class="classification">thiazide diuretic</span><br/><b>Prototype: </b>Hydrochlorothiazide<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg, 2 mg, 4 mg</p>
<h1><a name="action">Actions</a></h1>
<p>Benzothiadiazine (thiazide) derivative. Diuretic action is associated with drug interference with transport of sodium ions
         across renal tubular epithelium. Enhances excretion of sodium, chloride, potassium, bicarbonates and water.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Reduces edema and results in a hypotensive action.</p>
<h1><a name="uses">Uses</a></h1>
<p>Primary agent in antihypertensive treatment and adjunctively in the management of edema associated with CHF, renal pathology,
         and hepatic cirrhosis.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to other thiazides or sulfonamides; anuria; pregnancy (category D), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Kidney and liver dysfunction; SLE; gout; diabetes mellitus.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Edema</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 14 mg/d or q.o.d.<br/><br/><span class="indicationtitle">Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 24 mg/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.020.08 mg/kg/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give drug early in morning after eating (to reduce gastric irritation) and to prevent interrupted sleep because of diuresis.</li>
<li>Store drug in tightly closed container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Hematologic:</span> <span class="speceff-life">Agranulocytosis</span>, vascular thrombosis. <span class="typehead">Metabolic:</span> <span class="speceff-common">Hyperuricemia, hypokalemia, hyperglycemia.</span> <span class="typehead">Body as a Whole:</span> Orthostatic hypotension, hepatic encephalopathy, photosensitivity. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Amphotericin B,</b> <span class="classification">corticosteroids</span> increase hypokalemic effects; may antagonize hypoglycemic effects of <b>insulin,</b> <span class="classification">sulfonylureas</span>; <b>cholestyramine,</b> <b>colestipol</b> decrease thiazide absorption; intensifies hypoglycemic and hypotensive effects of <b>diazoxide.</b> Increased <b>potassium</b> and <b>magnesium</b> loss may cause <b>digoxin</b> toxicity; decreases <b>lithium</b> excretion, increasing its toxicity; <span class="classification">nsaids</span> may attenuate diuresis and increase risk of <span class="classification">nsaid</span>-induced kidney failure. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span>  2 h. <span class="typehead">Peak:</span> 6 h. <span class="typehead">Duration:</span> 2448 h. <span class="typehead">Distribution:</span> Distributed throughout extracellular tissue; concentrates in kidney; crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Does not appear to be metabolized. <span class="typehead">Elimination:</span> Excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Older adult patients may be more sensitive to the average adult therapeutic dose. Excessive diuresis may induce sudden hypotension
            and serious electrolyte imbalance.
         </li>
<li>Be aware that antihypertensive effects may be noted in 34 d; maximal effects may require 34 wk. Effects persist
            for at least 1 wk after drug is discontinued.
         </li>
<li>Lab tests: Periodic serum electrolytes and blood glucose.</li>
<li>Monitor for S&amp;S of hypokalemia and hyperglycemia (see Appendix F).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Change position slowly and in stages, particularly from lying down to upright positions; avoid hot baths or showers, extended
            exposure to sunlight, and standing still.
         </li>
<li>Include specific sources of potassium in daily diet such as a banana (about 370 mg potassium) and at least 180 mL (6 oz) orange
            juice (about 330 mg potassium).
         </li>
<li>Monitor blood glucose for loss of glycemic control of diabetic.</li>
<li>Be aware of the possibility of photosensitivity reaction and notify physician if it occurs. Thiazide-related photosensitivity
            is considered a photoallergy and occurs 1014 d after initial sun exposure. Use sunscreen lotion with a high SPF (1215).
         </li>
<li>Avoid OTC drugs unless approved by the physician. Many preparations contain both potassium and sodium and if misused can induce
            electrolyte adverse effects.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>